CTSO — Cytosorbents Crp · rev $18.5M

Cytosorbents Crp (CTSO) is a medical devices company listed on US.

Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.

Use this CTSO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CTSO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CTSO SEC filings page. Lician reads the product cache first so this HTML stays unique to Cytosorbents Crp even when a live quote feed is slow.

Cytosorbents Crp latest statements (FY2025)

Latest cached year on this hub. Full CTSO income, balance, and cash tables.

  • Revenue$37.1M
  • Net Income-$8.2M
  • Total Assets$44.2M
  • Total Debt$0
  • Free Cash Flow-$12.5M

CTSO recent filings